First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial
Webb, A., Cunningham, D., Cotter, F., Ross, P., Walters, J., Judson, I., Raynaud, F., Clarke, P., Dziewanowska, Z.E.Volume:
33
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(97)86090-X
Date:
September, 1997
File:
PDF, 228 KB
english, 1997